“CSL has an outstanding track record over the long term,” said David Grace of the Australian Foundation Investment Company, which owns about A$629 million of the company’s shares and has been invested ...
Alzheimer’s disease is a long, slow neurodegenerative calamity, and scientists are still hunting for blood biomarkers that reflect all its specific stages. At the Clinical Trials on Alzheimer’s ...
We compared common BAL correction methods—albumin, total protein and epithelial lining fluid (ELF ... Then, 9.6 mL of whole blood in lithium heparin tubes underwent centrifugation for 10 min at ...